Lebrikizumab Monotherapy Reduces Flares in Patients with Moderate-to-Severe Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 2, p. s147, 2023. DOI: 10.25251/skin.7.supp.147. Disponível em: https://skin.dermsquared.com/skin/article/view/1949. Acesso em: 18 apr. 2025.